AIR Therapy for Gulf War Syndrome
(GWAIR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a sleep treatment can improve sleep and other symptoms for Gulf War Veterans with Gulf War Illness (GWI). The treatment, Apnea and Insomnia Relief (AIR), includes six telehealth sessions focused on sleep education and strategies to manage sleep disorders like apnea (a condition causing breathing to stop and start during sleep) and insomnia (trouble sleeping). Veterans who served in the Gulf War and have sleep problems linked to GWI, along with a diagnosis of obstructive sleep apnea, might be ideal candidates. The goal is to determine if improving sleep also alleviates other GWI symptoms, such as fatigue and mood issues. As an unphased trial, this study offers a unique opportunity to contribute to understanding and improving treatments for Gulf War Illness.
Will I have to stop taking my current medications?
The trial requires that you stay on your current medications if you are taking benzodiazepines, anticonvulsants, atypical antipsychotics, or certain antidepressants like trazodone, as long as you meet the criteria for insomnia disorder and have sleep apnea. You should not start or stop any antidepressant, anxiety, or sleep medications within one month before joining the trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Apnea and Insomnia Relief (AIR) treatment aims to help Gulf War Veterans with sleep issues such as apnea (breathing problems during sleep) and insomnia (difficulty sleeping). This treatment involves learning about sleep, using motivation techniques, and adopting better sleep habits.
While specific safety data for AIR is limited, its components are generally safe and commonly used. One part of AIR, cognitive behavioral therapy for insomnia (CBT-I), is a standard and well-tolerated method. Other elements, like educational sessions and motivational talks, are also safe and widely used in similar programs.
Despite the lack of specific safety data from past studies for AIR, it is reasonable to consider AIR well-tolerated due to its use of established and safe methods to improve sleep. Participants should discuss any concerns with the trial staff to ensure it is a suitable option for them.12345Why are researchers excited about this trial?
Researchers are excited about the Apnea and Insomnia Relief (AIR) therapy because it combines several innovative approaches to tackle Gulf War Syndrome. Unlike standard treatments, which often focus on sleep aids or medication, AIR incorporates psychoeducation, motivational interviewing, and cognitive behavioral therapy for insomnia (CBT-I), all delivered via telehealth. This method not only addresses the root causes of sleep issues but also promotes better adherence to positive airway pressure (PAP) therapy through personalized strategies. By integrating these elements, AIR offers a comprehensive, non-pharmacological approach that could improve sleep quality for individuals with this condition, potentially leading to better overall health outcomes.
What evidence suggests that this trial's treatments could be effective for Gulf War Syndrome?
Research has shown that cognitive behavioral therapy for insomnia (CBT-I) can help veterans with Gulf War Illness (GWI) sleep better and feel better overall. Studies have found that providing CBT-I over the phone improves both sleep and other symptoms of GWI. In this trial, participants may receive the Apnea and Insomnia Relief (AIR) treatment, which includes CBT-I and other methods to promote healthy sleep. Early results suggest this combined approach may help veterans with GWI who have trouble sleeping, potentially leading to better sleep and improved symptoms. Another group in this trial will receive Sleep Education (SE), which covers topics such as the sleep cycle and sleep environment.12467
Who Is on the Research Team?
Linda L Chao, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for Gulf War Veterans aged 48-80 with Gulf War Illness (GWI) who have sleep disorders like insomnia and obstructive sleep apnea, confirmed by a doctor. Participants must meet specific GWI criteria, have internet at home, and not be involved in other trials or starting/stopping certain medications or therapies within the last month.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive behavioral sleep treatment over six sessions via telehealth or telephone
Follow-up
Participants are monitored for changes in Gulf War Illness symptom severity and PAP adherence
What Are the Treatments Tested in This Trial?
Interventions
- Apnea and Insomnia Relief (AIR)
- Sleep Education (SE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
San Francisco VA Health Care System
Collaborator
United States Department of Defense
Collaborator